Ronald Piervincenzi’s Post

It's showtime here on Day 1 at Vietnam Medipharm Expo in Ho Chi Minh City!! Not reputed to be a typical pharmaceutical event and definitely not an API centric one, we still thought of giving it a try! And you know what? I'm definitely glad we did! After a disappointing CPHI South East Asia, trust me, expectations were kept to a bare minimal! And I guess when expectations are lowered, we can only be pleasantly surprised! Vietnam is a super fast developing market that is positioning itself along the standards of EU GMP. Not our typical WHO GMP Indian standards. What's frightening is the growing lack of confidence of Vietnamese importers in the WHO GMP manufacturers of India. To say the least, WHO GMP just doesn't seem enough. A PIC/s or EU GMP is by far more acceptable. In fact, it's preferable. In some cases even, demanded. Makes me wonder if it's only Vietnam that feels this way or is the world starting to raise an eyebrow at Indian standards of manufacturing. And possibly questioning India's status as the pharmacy of the world. This is something to surely keep a close eye on and improve upon before it's too late. Reputation takes decades to build and just minutes to destroy. The few that spoil the name of many need to be halted right here right now. Indian pharma's reputation can't be compromised by these greedy and sleazy few - and in no way, should any of us, part of the Indian pharma fraternity, accept the rotten bunch to thrive and prosper at our cost. The same applies for APIs. High quality of finished products starts with high quality of raw materials. No cost cutting here please. Luckily for Shah TC and Xi He , Vietnam understands that. And fortunately for Vietnam, so do we. Stay tuned for Day 2 tommorow! 📽 A special big thanks to Sisy Jiang, our resident South East Asia manager and her cutie little boy, for a wonderfully entertaing first day here! Video courtesy: Sisy Jiang #withshahtc #masterplan #xihe #pharma #Vietnam #API #FDF #distribution #quality #supplychain #manufacturing

Regulatory Intelligence Updates. Following recent developments in regulatory affairs in the African market, here are a few updates from Kenya and Nigeria. Pharmacy and Poisons Board National Agency for Food and Drug Administration and Control (NAFDAC) East African Regulatory Affairs Professionals Association (EARAPA)

Hear from Vedaant Shourie (वेदांत शौरी) at the World Drug Safety Congress Europe in October! Vedaant is SME, PV Business & Systems Implementations at Pinnaxis and will be speaking about 'Constantly Evolving Device Regulations' at the event. Learn more 👉 https://lnkd.in/egjKcWgA #dseu #drugsafety

In this series, SAPI shines a spotlight on the different working committee groups within the organization that work towards achieving our goal of making innovative medicine accessible to patients in Singapore. Our Regulatory Affairs Committee (RAC) is headed by Ms Celine Ting, who has served on the SAPI Board of Directors for over 17 years. The RAC is the largest committee in SAPI, comprised of about 50 members from 33 companies. It plays a crucial role in ensuring the quality and compliance of every stage of drug development, from research and manufacturing to distribution, is rigorously upheld to the highest standards thus contributing to shaping Singapore's pharmaceutical industry regulatory landscape. Kum Cheun (KC) Wong Michelle Cheng Weng Yew Low Lifen Tan Pearle Liew Lee Mei Liew Helen Ling Jimmy Teo Giang Nguyen Rapidah Md Hani Christina KEOK Siew Jin Chen Cindy Z. Farrah Edrous Lim Liang Jun Jennifer Lim Angeline Lim Joanne A. Sok Bee Lim Bee Koon Aw Sharron Lim Kwee Foong Leow Althea Lau Rozita Ishak Wai Keng (Rachel) CHAI Ka Lok Cheung Siew Wai Ng Kai Kiong (KK) Lim, RAC, MPSS. Perlynn Cheong Sandy Chan Kee Wee Tay Ai Mei (Ivy) Ng Ernestine Angela Sarne Siew Hong Lek Tricia Chean Eunice Chen Andiyanto Sutandar Agnes Heng Anuradha Arunachalam Tse Siang Kang Serene Huang Si Jia Tan Rachel Chua Joanne Seow Stephanie Ong Shirley Yong Jacqueline Wong David Chin Ding Ruenn Ing Azlina Rahman Ho Lip Yong Fauziah Othman Cheong Zu Hui Tey Aik Han #SAPI #SAPIspotlight #regulatoryaffairs #alwaysinnovating #regulatoryexcellence